# A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers

> **NCT07544589** · PHASE1 · RECRUITING · sponsor: **Dispatch Biotherapeutics** · enrollment: 66 (estimated)

## Conditions studied

- Colorectal Cancer
- Gastric Adenocarcinoma
- Esophageal Adenocarcinoma
- Gastroesophageal Adenocarcinoma

## Interventions

- **BIOLOGICAL:** DISP-10

## Key facts

- **NCT ID:** NCT07544589
- **Lead sponsor:** Dispatch Biotherapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2046-04
- **Final completion:** 2046-04
- **Target enrollment:** 66 (ESTIMATED)
- **Last updated:** 2026-04-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07544589

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07544589, "A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07544589. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*